Trans-Hit Bio

Laval, Canada Founded: 2009 • Age: 17 yrs Acquired By Brooks Automation
Tissue examination services are offered by this CRO in Canada.
Request Access

About Trans-Hit Bio

Trans-Hit Bio is a company based in Laval (Canada) founded in 2009 by Pascal Puchois was acquired by Brooks Automation in December 2020.. Trans-Hit Bio operates in a competitive market with competitors including Asterand Bioscience, Pulse Medical Imaging Technology, StageBio, Numira and Numira Biosciences, among others.

  • Headquarter Laval, Canada
  • Founders Pascal Puchois
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Brooks Automation

    (Dec 03, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Trans-Hit Bio

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Trans-Hit Bio

Trans-Hit Bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Brooks Automation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Vacuum robots for semiconductor wafer handling are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Trans-Hit Bio

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Trans-Hit Bio

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Trans-Hit Bio Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Trans-Hit Bio

Trans-Hit Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asterand Bioscience, Pulse Medical Imaging Technology, StageBio, Numira and Numira Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Human tissue solutions for drug discovery research are supplied globally.
domain founded_year HQ Location
Cardiac imaging services are offered by CRO in Shanghai.
domain founded_year HQ Location
Preclinical pathology services are provided for research and development needs.
domain founded_year HQ Location
Numira is a specialty preclinical CRO specializing in microCT imaging, image analysis, histology, and 3D cancer cell profiling.
domain founded_year HQ Location
Online platform for fast deposits and retail in electronics and fashion categories.
domain founded_year HQ Location
Provider of clinical trials support & software services for medical devices manufacturers
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Trans-Hit Bio

When was Trans-Hit Bio founded?

Trans-Hit Bio was founded in 2009.

Where is Trans-Hit Bio located?

Trans-Hit Bio is headquartered in Laval, Canada. It is registered at Laval, Quebec, Canada.

Who is the current CEO of Trans-Hit Bio?

Pascal Puchois is the current CEO of Trans-Hit Bio. They have also founded this company.

What does Trans-Hit Bio do?

Trans-Hit Bio was established in 2009 in Laval, Canada, as a contract research organization (CRO) in the biotechnology sector. Tissue examination services are provided to support pharmaceutical and research needs. Operations are centered on histological analysis and related expertise. The company is led by founder and CEO Pascal Puchois, with its online presence maintained at trans-hit.com.

Who are the top competitors of Trans-Hit Bio?

Trans-Hit Bio's top competitors include Asterand Bioscience, Pulse Medical Imaging Technology and Radiomics.

Who are Trans-Hit Bio's investors?

Trans-Hit Bio has 1 investor. Key investors include Brooks Automation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available